Rubius Therapeutics Raises $100 Million in Crossover Financing Post author:Sam Post published:February 28, 2018 Post category:BioPharma Rubius Therapeutics has closed on an oversubscribed $100 million crossover financing. Source: BioSpace You Might Also Like Minerva Neurosciences Reports First Quarter 2017 Financial Results And Business Updates May 3, 2017 AstraZeneca Shows Off New Farxiga Data for Diabetes Patients with Chronic Kidney Disease March 19, 2018 Seegene Enters The U.S. Diagnostic Market In Collaboration With Thermo Fisher Scientific May 22, 2017
AstraZeneca Shows Off New Farxiga Data for Diabetes Patients with Chronic Kidney Disease March 19, 2018
Seegene Enters The U.S. Diagnostic Market In Collaboration With Thermo Fisher Scientific May 22, 2017
